BioFreedom™ BA9™ Ultra

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

July 21, 2022

Study Completion Date

January 21, 2024

Conditions
Cardiovascular DeathMyocardial InfarctionRevascularization
Interventions
DEVICE

BioFreedom BA9 (SS) Ultra DCS

BioFreedom Ultra stent for treatment of STEMI patients. Besides, in patients who are clinically indicated for a stage procedure, we aim to assess the angiographic and endovascular healing of BioFreedom Ultra stent at one month

Trial Locations (1)

Unknown

RECRUITING

The University of Hong Kong, Hong Kong

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biosensors International

OTHER

lead

The University of Hong Kong

OTHER